MedTrace Logo

Rehabilitation and Return to Everyday Life for Patients With Long COVID

NCT06544382 · Status: ACTIVE_NOT_RECRUITING · Type: OBSERVATIONAL · Enrollment: 914

Last updated 2024-08-14

No results posted yet for this study

Summary

This non-randomised controlled trial will investigate if patients with long COVID receiving a structured and group-based rehabilitation intervention (The Long COVID Rehabilitation Intervention) will report a difference in mean change in self-reported mental fatigue measured by Mental Fatigue Scale and will report a mean difference in weeks of sick-leave obtained through the Danish Register for Evaluation of Marginalisation compared to usual practise over a 12-month follow-up period. Alongside the effectiveness evaluation, a economic evaluation study and process evaluation study will be conducted,

Patients from Aarhus Municipality, Central Denmark Region, Denmark, receive The Long COVID Rehabilitation Intervention and will be allocated to the intervention group. Patients receiving rehabilitation in the other municipalities of Central Denmark Region, Denmark, will be allocated to the control group. Alongside this, a health economic study and a process evaluation study will be conducted.

Conditions

Interventions

OTHER

The Long COVID Rehabilitation Intervention

The intervention is a structured rehabilitation intervention with a duration of minimum 3 months comprising 4-12 individual sessions and 1-4 group-based courses delivered by physiotherapists and occupational therapists.

OTHER

Usual care

A less structured rehabilitation programme comprising individual session with a few group options with patients with long COVID or mixed diagnoses.

Sponsors & Collaborators

  • Aarhus University Hospital

    collaborator OTHER

  • VIA University College

    collaborator OTHER

  • University of Aarhus

    collaborator OTHER

  • Aarhus Municipality, Denmark

    collaborator OTHER

  • Defactum, Central Denmark Region

    lead OTHER_GOV

Principal Investigators

  • Lisa Oestergaard Gregersen, PhD · DEFACTUM, Central Denmark Region, and Department of Public Health, Aarhus University

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2020-11-23
Primary Completion
2026-08-31
Completion
2026-08-31

Countries

  • Denmark

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT06544382 on ClinicalTrials.gov